These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 4577688)

  • 21. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus.
    Yang CS; Hewetson JF
    Int J Cancer; 1974 Oct; 14(4):530-8. PubMed ID: 4376526
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunological aspects of the pathology of the oral cavity].
    Robotti MP; Azzolina LS; Tridente G
    Recenti Prog Med; 1984; 75(7-8):692-715. PubMed ID: 6095383
    [No Abstract]   [Full Text] [Related]  

  • 23. Human tumor immunology.
    Oettgen HF; Old LJ; Boyse EA
    Med Clin North Am; 1971 May; 55(3):761-85. PubMed ID: 4995918
    [No Abstract]   [Full Text] [Related]  

  • 24. [Leukocyte migration inhibition elicited by Epstein-Barr virus antigen. Reaction potential in infectious mononucleosis as well as in states of immune deficiency and immunosuppression].
    Szigeti R; Klein E; Masucci MG; Ernberg I; Masucci G; Svedmyr E; Klein G
    Orv Hetil; 1982 May; 123(20):1217-21. PubMed ID: 6287380
    [No Abstract]   [Full Text] [Related]  

  • 25. Survey of the methodological approaches to studying delayed hypersensitivity in vitro.
    Pekarek J; Krejci J
    J Immunol Methods; 1974 Dec; 6(1-2):1-22. PubMed ID: 4612071
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanisms of immunodepression induced by viruses: possible role of infected macrophages.
    Virelizier JL
    Biomedicine; 1975 Jul; 22(4):255-61. PubMed ID: 58678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular immunity in infectious mononucleosis: I. Spontaneous and phytohaemagglutinin-induced blast transformation in infectious mononucleosis, with special reference to depressed cellular reactivity and stimulation-blocking serum factors.
    Nikoskelainen J; Stevens DA; Neel EU; Isenberg RA; Miller RG; Halpern JW; Gelpi AP
    IARC Sci Publ (1971); 1978; (24 Pt 2):699-709. PubMed ID: 751903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of continuous lymphoblast cultures from leukocytes of gibbons (Hylobates lar).
    Werner J; Henle G; Pinto CA; Haff RF; Henle W
    Int J Cancer; 1972 Nov; 10(3):557-67. PubMed ID: 4358039
    [No Abstract]   [Full Text] [Related]  

  • 29. Macrophage function in the development of immunocompetence and in immunodeficiency.
    Blaese RM
    J Reticuloendothel Soc; 1976 Jul; 20(1):67-70. PubMed ID: 1084927
    [No Abstract]   [Full Text] [Related]  

  • 30. Host responses to herpesviruses - a review.
    Henle W; Henle G
    IARC Sci Publ (1971); 1975; (11 Pt 2):215-24. PubMed ID: 191365
    [No Abstract]   [Full Text] [Related]  

  • 31. Epstein-Barr virus and human disease: immune responses determine the clinical and pathologic expression.
    Purtilo DT; Sakamoto K
    Hum Pathol; 1981 Aug; 12(8):677-9. PubMed ID: 6269987
    [No Abstract]   [Full Text] [Related]  

  • 32. Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators.
    David JR; David RR
    Prog Allergy; 1972; 16():300-449. PubMed ID: 4564107
    [No Abstract]   [Full Text] [Related]  

  • 33. Malignancy as a complication of immunosuppressive therapy.
    Leibowitz S; Schwartz RS
    Adv Intern Med; 1971; 17():95-123. PubMed ID: 4145004
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of immune processes on the growth and regression of malignant tumors].
    Russo V; Russo L
    Vopr Onkol; 1974; 20(6):68-75. PubMed ID: 4603500
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunologic studies in Burkitt's lymphoma.
    Ziegler JL; Cohen MH; Morrow RH; Kyalwazi SK; Carbone PP
    Cancer; 1970 Mar; 25(3):734-9. PubMed ID: 4984654
    [No Abstract]   [Full Text] [Related]  

  • 36. Interactions of antibodies, complement components and various cell types in immunity against viruses and pyogenic bacteria.
    Allison AC
    Transplant Rev; 1974; 19(0):3-55. PubMed ID: 4135465
    [No Abstract]   [Full Text] [Related]  

  • 37. Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. IV. Differentiation between antibodies responsible for membrane and viral immunofluorescence.
    Pearson G; Klein G; Henle G; Henle W; Clifford P
    J Exp Med; 1969 Apr; 129(4):707-18. PubMed ID: 4886045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infectious mononucleosis fifty years after the discovery of the Paul-Bunnell test.
    Burgio GR; Monafo V
    Infection; 1983; 11(1):1-5. PubMed ID: 6302006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of antilymphocytic serum on bacterial and viral infections and virus oncogenesis.
    Allison AC
    Fed Proc; 1970; 29(1):167-8. PubMed ID: 4312736
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunological activation of oncogenic viruses: interrelationship of immunostimulation and immunosuppression.
    Hirsch MS
    Johns Hopkins Med J Suppl; 1974; 3():177-85. PubMed ID: 4153909
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.